Nifty
Sensex
:
:
23501.10
77209.90
-65.90 (-0.28%)
-269.03 (-0.35%)

Pharmaceuticals & Drugs - API

Rating :
63/99

BSE: 524558 | NSE: NEULANDLAB

6571.70
21-Jun-2024
  • Open
  • High
  • Low
  • Previous Close
  •  6540.00
  •  6600.00
  •  6463.00
  •  6552.15
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  14108
  •  922.37
  •  7790.00
  •  2745.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 8,418.52
  • 28.05
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 8,384.24
  • 0.21%
  • 6.57

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 32.74%
  • 5.18%
  • 27.97%
  • FII
  • DII
  • Others
  • 24.43%
  • 4.28%
  • 5.40%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.85
  • 12.30
  • 8.33

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.43
  • 36.03
  • 13.11

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 19.82
  • 58.32
  • 26.58

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 31.00
  • 28.12
  • 25.94

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.22
  • 2.79
  • 3.54

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 14.29
  • 13.68
  • 14.23

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Net Sales
385.01
407.07
-5.42%
392.83
269.25
45.90%
417.75
293.71
42.23%
362.99
221.17
64.12%
Expenses
278.09
287.21
-3.18%
271.56
215.17
26.21%
280.26
224.41
24.89%
266.07
192.57
38.17%
EBITDA
106.92
119.86
-10.80%
121.27
54.08
124.24%
137.49
69.30
98.40%
96.92
28.60
238.88%
EBIDTM
27.77%
29.44%
30.87%
20.09%
32.91%
23.59%
26.70%
12.93%
Other Income
5.36
8.06
-33.50%
2.10
0.93
125.81%
3.05
0.24
1,170.83%
2.04
0.51
300.00%
Interest
3.61
4.29
-15.85%
3.74
2.75
36.00%
4.43
3.17
39.75%
2.21
2.86
-22.73%
Depreciation
16.46
13.47
22.20%
15.14
13.34
13.49%
14.51
13.17
10.17%
13.59
12.80
6.17%
PBT
92.20
110.16
-16.30%
104.48
38.94
168.31%
121.59
53.19
128.60%
83.16
13.46
517.83%
Tax
24.64
25.62
-3.83%
23.09
8.39
175.21%
32.35
14.73
119.62%
21.28
3.49
509.74%
PAT
67.56
84.54
-20.09%
81.39
30.55
166.42%
89.25
38.46
132.06%
61.88
9.97
520.66%
PATM
17.55%
20.77%
20.72%
11.35%
21.36%
13.10%
17.05%
4.51%
EPS
52.37
65.53
-20.08%
63.09
23.68
166.43%
69.18
29.81
132.07%
47.96
7.73
520.44%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Net Sales
1,558.58
1,191.20
951.08
936.91
762.71
666.83
527.41
578.89
509.97
469.15
465.69
Net Sales Growth
30.84%
25.25%
1.51%
22.84%
14.38%
26.43%
-8.89%
13.51%
8.70%
0.74%
 
Cost Of Goods Sold
577.28
478.23
422.14
438.42
380.20
366.24
238.37
262.90
253.46
243.99
246.53
Gross Profit
981.30
712.97
528.94
498.50
382.51
300.59
289.04
315.99
256.52
225.16
219.16
GP Margin
62.96%
59.85%
55.61%
53.21%
50.15%
45.08%
54.80%
54.59%
50.30%
47.99%
47.06%
Total Expenditure
1,095.98
919.36
808.46
790.09
660.82
608.46
476.98
472.55
429.52
402.53
395.08
Power & Fuel Cost
-
48.62
42.21
39.21
32.75
26.81
25.95
25.78
22.24
22.53
18.31
% Of Sales
-
4.08%
4.44%
4.19%
4.29%
4.02%
4.92%
4.45%
4.36%
4.80%
3.93%
Employee Cost
-
201.79
182.47
149.74
123.56
110.46
102.99
92.74
65.38
51.81
41.74
% Of Sales
-
16.94%
19.19%
15.98%
16.20%
16.56%
19.53%
16.02%
12.82%
11.04%
8.96%
Manufacturing Exp.
-
86.94
89.16
77.10
64.84
50.10
55.54
44.90
39.31
43.56
40.98
% Of Sales
-
7.30%
9.37%
8.23%
8.50%
7.51%
10.53%
7.76%
7.71%
9.28%
8.80%
General & Admin Exp.
-
51.22
35.80
38.93
27.75
27.49
33.32
28.30
29.72
23.59
15.95
% Of Sales
-
4.30%
3.76%
4.16%
3.64%
4.12%
6.32%
4.89%
5.83%
5.03%
3.43%
Selling & Distn. Exp.
-
29.58
27.40
34.63
18.30
18.28
14.04
11.16
17.52
14.54
26.57
% Of Sales
-
2.48%
2.88%
3.70%
2.40%
2.74%
2.66%
1.93%
3.44%
3.10%
5.71%
Miscellaneous Exp.
-
22.99
9.28
12.08
13.42
9.08
6.77
6.78
1.89
2.52
26.57
% Of Sales
-
1.93%
0.98%
1.29%
1.76%
1.36%
1.28%
1.17%
0.37%
0.54%
1.07%
EBITDA
462.60
271.84
142.62
146.82
101.89
58.37
50.43
106.34
80.45
66.62
70.61
EBITDA Margin
29.68%
22.82%
15.00%
15.67%
13.36%
8.75%
9.56%
18.37%
15.78%
14.20%
15.16%
Other Income
12.55
9.75
2.08
16.10
3.89
3.49
4.53
1.17
1.78
0.78
3.44
Interest
13.99
13.07
13.50
17.90
21.57
15.66
18.93
21.09
24.48
27.36
24.56
Depreciation
59.70
52.78
49.04
39.68
31.28
25.86
22.10
19.23
15.74
15.32
14.94
PBT
401.43
215.75
82.16
105.33
52.92
20.34
13.93
67.19
42.00
24.72
34.55
Tax
101.36
52.23
18.34
24.70
36.71
3.90
1.87
20.32
14.92
8.79
7.80
Tax Rate
25.25%
24.21%
22.32%
23.45%
69.37%
19.17%
13.42%
30.24%
35.52%
35.56%
22.58%
PAT
300.08
163.52
63.82
80.63
16.21
16.44
12.06
46.86
27.33
15.94
26.80
PAT before Minority Interest
300.08
163.52
63.82
80.63
16.21
16.44
12.06
46.86
27.08
15.93
26.75
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.25
0.01
0.05
PAT Margin
19.25%
13.73%
6.71%
8.61%
2.13%
2.47%
2.29%
8.09%
5.36%
3.40%
5.75%
PAT Growth
83.51%
156.22%
-20.85%
397.41%
-1.40%
36.32%
-74.26%
71.46%
71.46%
-40.52%
 
EPS
234.44
127.75
49.86
62.99
12.66
12.84
9.42
36.61
21.35
12.45
20.94

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Shareholder's Funds
994.10
840.50
786.46
709.96
699.31
558.04
545.62
186.63
161.38
123.99
Share Capital
12.90
12.90
12.90
12.90
12.90
8.95
8.95
8.95
8.95
7.73
Total Reserves
981.20
827.60
773.56
697.06
686.41
238.24
225.81
177.68
152.42
116.26
Non-Current Liabilities
146.71
179.83
169.82
163.39
104.06
146.43
54.37
69.42
54.76
52.33
Secured Loans
74.25
104.25
88.13
77.37
60.72
103.49
29.81
33.40
21.22
8.87
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
12.00
12.00
25.00
Long Term Provisions
10.29
11.91
9.44
12.49
11.91
9.87
9.28
6.85
6.38
5.14
Current Liabilities
438.96
363.16
368.51
357.63
326.98
366.93
285.60
268.00
295.14
306.90
Trade Payables
171.01
117.38
152.13
115.56
119.68
124.29
85.92
83.86
111.81
93.94
Other Current Liabilities
244.87
152.35
158.75
71.63
57.45
41.83
47.18
55.02
31.28
63.74
Short Term Borrowings
11.16
92.21
56.98
168.17
149.06
199.20
151.08
123.63
145.80
139.62
Short Term Provisions
11.93
1.21
0.64
2.27
0.80
1.59
1.41
5.50
6.25
9.61
Total Liabilities
1,579.77
1,383.49
1,324.79
1,230.98
1,130.35
1,071.40
885.59
524.05
511.53
483.48
Net Block
738.19
747.70
696.94
622.76
511.69
445.01
435.74
138.77
123.07
130.85
Gross Block
953.26
913.27
826.48
714.33
575.44
483.45
454.74
291.78
263.65
258.54
Accumulated Depreciation
215.07
165.57
129.54
91.57
63.75
38.44
19.00
153.00
140.58
127.69
Non Current Assets
818.87
802.70
775.20
715.79
676.88
624.20
510.54
209.87
195.76
195.93
Capital Work in Progress
40.57
20.46
17.25
23.75
104.47
126.09
19.60
40.48
41.47
34.56
Non Current Investment
0.52
0.50
19.35
30.17
30.21
30.21
30.20
7.39
7.39
7.36
Long Term Loans & Adv.
20.24
14.38
41.67
35.81
30.51
22.66
24.79
22.73
23.83
23.15
Other Non Current Assets
0.00
0.00
0.00
3.30
0.00
0.22
0.22
0.50
0.00
0.00
Current Assets
760.89
580.79
549.59
515.19
453.47
447.19
375.04
314.19
315.77
287.55
Current Investments
0.00
3.38
6.46
7.50
7.50
7.50
7.50
0.00
0.00
0.00
Inventories
279.23
265.21
247.61
219.55
192.65
175.09
135.11
126.66
113.40
93.42
Sundry Debtors
361.77
234.33
217.73
189.89
164.02
193.92
181.11
119.11
128.85
118.59
Cash & Bank
59.10
20.36
19.40
46.98
37.84
17.26
12.49
9.71
6.98
7.07
Other Current Assets
60.79
11.52
8.84
17.47
51.46
53.43
38.83
58.70
66.53
68.47
Short Term Loans & Adv.
47.09
46.00
49.55
33.80
31.77
37.15
25.30
46.68
45.23
43.01
Net Current Assets
321.94
217.64
181.08
157.55
126.49
80.27
89.45
46.18
20.63
-19.35
Total Assets
1,579.76
1,383.49
1,324.79
1,230.98
1,130.35
1,071.39
885.58
524.06
511.53
483.48

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Cash From Operating Activity
237.21
60.39
189.36
57.34
69.91
11.27
38.68
44.83
13.17
48.77
PBT
215.75
82.16
105.33
52.92
20.34
13.93
67.19
42.00
24.72
34.55
Adjustment
76.05
66.30
40.08
58.28
39.11
40.43
43.96
33.73
36.34
34.37
Changes in Working Capital
-10.96
-67.58
49.22
-49.17
15.47
-40.02
-55.94
-19.17
-38.76
-16.82
Cash after chg. in Working capital
280.84
80.88
194.63
62.03
74.91
14.35
55.20
56.56
22.30
52.11
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-43.63
-20.49
-5.27
-4.68
-5.01
-3.08
-16.52
-11.73
-9.13
-3.34
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-61.50
-95.52
-84.42
-48.68
-77.23
-116.29
-42.11
-19.86
-14.13
-9.84
Net Fixed Assets
-60.11
-90.00
-105.64
-58.17
-70.35
-135.20
-142.08
-27.14
-12.02
-7.02
Net Investments
3.36
21.92
11.87
0.04
0.00
-0.01
-30.31
0.12
-0.03
0.00
Others
-4.75
-27.44
9.35
9.45
-6.88
18.92
130.28
7.16
-2.08
-2.82
Cash from Financing Activity
-135.80
37.72
-113.66
-5.48
11.98
104.85
-0.09
-23.62
1.15
-38.96
Net Cash Inflow / Outflow
39.92
2.59
-8.72
3.18
4.66
-0.17
-3.51
1.35
0.19
-0.03
Opening Cash & Equivalents
5.09
2.44
11.20
7.94
3.29
3.44
6.97
0.81
0.62
0.65
Closing Cash & Equivalent
45.42
5.09
2.44
11.20
7.94
3.29
3.44
2.16
0.81
0.62

Financial Ratios

Consolidated /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Book Value (Rs.)
774.12
654.40
612.28
552.65
544.35
277.21
263.23
209.07
180.72
153.48
ROA
11.04%
4.71%
6.31%
1.37%
1.49%
1.23%
6.65%
5.23%
3.20%
5.89%
ROE
17.84%
7.85%
10.79%
2.30%
3.48%
5.02%
22.34%
15.64%
11.24%
24.14%
ROCE
20.94%
9.44%
12.81%
7.85%
3.99%
4.07%
15.98%
18.57%
15.75%
18.99%
Fixed Asset Turnover
1.28
1.09
1.22
1.18
1.26
1.13
1.57
1.86
1.82
1.87
Receivable days
91.33
86.74
79.40
84.68
97.96
129.34
93.22
87.45
94.81
83.45
Inventory Days
83.41
98.40
91.00
98.63
100.64
106.98
81.29
84.66
79.24
71.34
Payable days
110.05
116.52
111.44
65.43
75.72
82.06
67.03
85.01
92.70
82.14
Cash Conversion Cycle
64.68
68.63
58.96
117.88
122.89
154.27
107.48
87.10
81.35
72.66
Total Debt/Equity
0.12
0.28
0.22
0.37
0.33
1.30
0.82
0.98
1.17
1.55
Interest Cover
17.51
7.09
6.89
3.45
2.30
1.74
4.19
2.72
1.90
2.41

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.